Earnings Feed
Start Free
Home/Filings/4/0000950172-05-001112
4//SEC Filing

QUESTCOR PHARMACEUTICALS INC 4

Accession 0000950172-05-001112

CIK 0000891288operating
View on SEC.govCompany Profile

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 6:43 PM ET

Size

18.9 KB

Accession

0000950172-05-001112

Insider Transaction Report

Form 4
Period: 2005-04-06
QUESTCOR PHARMACEUTICALS INCqsc
SIGMA TAU FINANZIARIA SPA
10% Owner
Transactions
  • Purchase

    Common Stock, no par value per share

    2005-04-06$0.71/sh+100,000$71,380→ 549,100 total(indirect: Shares directly held by Aptafin S.p.A.)
Holdings

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza.)
    1,756,781

  • Common Stock, no par value per share

    (indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
    759,493

  • 8% Convertible Debenture

    (indirect: The 8% Convertible Debenture is directly held by Defiante Farmaceutica L.d.A.)
    Exercise: $1.58Exp: 2005-04-15→ Common Stock, no par value per share (1,265,822 underlying)

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza.)
    1,756,782

  • Common Stock, no par value per share

    (indirect: Shares underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A.)
    1,265,822

  • Common Stock, no par value per share

    8,643,397
APTAFIN S P A
10% Owner
Transactions
  • Purchase

    Common Stock, no par value per share

    2005-04-06$0.71/sh+100,000$71,380→ 549,100 total(indirect: Shares directly held by Aptafin S.p.A.)
Holdings

  • Common Stock, no par value per share

    (indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
    759,493

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza.)
    1,756,781

  • 8% Convertible Debenture

    (indirect: The 8% Convertible Debenture is directly held by Defiante Farmaceutica L.d.A.)
    Exercise: $1.58Exp: 2005-04-15→ Common Stock, no par value per share (1,265,822 underlying)

  • Common Stock, no par value per share

    8,643,397

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza.)
    1,756,782

  • Common Stock, no par value per share

    (indirect: Shares underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A.)
    1,265,822
DEFIANTE FARMACEUTICA LDA
10% Owner
Transactions
  • Purchase

    Common Stock, no par value per share

    2005-04-06$0.71/sh+100,000$71,380→ 549,100 total(indirect: Shares directly held by Aptafin S.p.A.)
Holdings

  • 8% Convertible Debenture

    (indirect: The 8% Convertible Debenture is directly held by Defiante Farmaceutica L.d.A.)
    Exercise: $1.58Exp: 2005-04-15→ Common Stock, no par value per share (1,265,822 underlying)

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza.)
    1,756,781

  • Common Stock, no par value per share

    8,643,397

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza.)
    1,756,782

  • Common Stock, no par value per share

    (indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
    759,493

  • Common Stock, no par value per share

    (indirect: Shares underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A.)
    1,265,822
SIGMA TAU INTERNATIONAL SA
10% Owner
Transactions
  • Purchase

    Common Stock, no par value per share

    2005-04-06$0.71/sh+100,000$71,380→ 549,100 total(indirect: Shares directly held by Aptafin S.p.A.)
Holdings

  • Common Stock, no par value per share

    8,643,397

  • Common Stock, no par value per share

    (indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
    759,493

  • 8% Convertible Debenture

    (indirect: The 8% Convertible Debenture is directly held by Defiante Farmaceutica L.d.A.)
    Exercise: $1.58Exp: 2005-04-15→ Common Stock, no par value per share (1,265,822 underlying)

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza.)
    1,756,781

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza.)
    1,756,782

  • Common Stock, no par value per share

    (indirect: Shares underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A.)
    1,265,822
CAVAZZA PAOLO
10% Owner
Transactions
  • Purchase

    Common Stock, no par value per share

    2005-04-06$0.71/sh+100,000$71,380→ 549,100 total(indirect: Shares directly held by Aptafin S.p.A.)
Holdings

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza.)
    1,756,782

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza.)
    1,756,781

  • Common Stock, no par value per share

    8,643,397

  • Common Stock, no par value per share

    (indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
    759,493

  • Common Stock, no par value per share

    (indirect: Shares underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A.)
    1,265,822

  • 8% Convertible Debenture

    (indirect: The 8% Convertible Debenture is directly held by Defiante Farmaceutica L.d.A.)
    Exercise: $1.58Exp: 2005-04-15→ Common Stock, no par value per share (1,265,822 underlying)
CAVAZZA CLAUDIO
10% Owner
Transactions
  • Purchase

    Common Stock, no par value per share

    2005-04-06$0.71/sh+100,000$71,380→ 549,100 total(indirect: Shares directly held by Aptafin S.p.A.)
Holdings

  • Common Stock, no par value per share

    (indirect: Shares directly held by Paolo Cavazza.)
    1,756,782

  • Common Stock, no par value per share

    (indirect: Shares directly held by Claudio Cavazza.)
    1,756,781

  • 8% Convertible Debenture

    (indirect: The 8% Convertible Debenture is directly held by Defiante Farmaceutica L.d.A.)
    Exercise: $1.58Exp: 2005-04-15→ Common Stock, no par value per share (1,265,822 underlying)

  • Common Stock, no par value per share

    8,643,397

  • Common Stock, no par value per share

    (indirect: Shares underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A.)
    1,265,822

  • Common Stock, no par value per share

    (indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
    759,493
Footnotes (2)
  • [F1]Sigma-Tau Finanziaria S.p.A. owns 100% of the capital stock of Sigma-Tau International S.A. (f/k/a Sigma-Tau Finance Holding S.A.) and 58% of the capital stock of Defiante Farmaceutica L.d.A. Sigma-Tau International S.A. owns 42% of the capital stock of Defiante Farmaceutica L.d.A. Claudio Cavazza owns, directly and indirectly, 60% of Sigma-Tau Finanziaria S.p.A. and Paolo Cavazza owns, directly and indirectly, 40% of Sigma-Tau Finanziaria S.p.A. Paolo Cavazza also owns, directly and indirectly, 100% of Aptafin S.p.A.
  • [F2]Defiante Farmaceutica L.d.A., the holder of the 8% Convertible Debenture, may convert all or any portion of the debenture into Common Stock, no par value per share, at any time prior to the maturity date of April 15, 2005.

Documents

1 file

Issuer

QUESTCOR PHARMACEUTICALS INC

CIK 0000891288

→
Entity typeoperating
IncorporatedCA

Related Parties

1
  • filerCIK 0000891288

Filing Metadata

Form type
4
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 6:43 PM ET
Size
18.9 KB
View on SEC.gov